Differential effects of trans and polyunsaturated fatty acids on ischemia/ reperfusion injury and its associated cardiovascular disease states

Current Pharmaceutical Design

Volumn 19, Issue 39, 2013, Pages 6858-6863

  Ganguly, Riya ^a,b   Lytwyn, Matthew S ^a,b   Pierce, Grant N ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Atherosclerosis; Fatty acid; Heart disease; Ischemia; Omega 3 fatty acid; Polyunsaturated fatty acid; Reperfusion; Trans fat

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHANNEL L TYPE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOSOLIC PHOSPHOLIPASE A2; DNA NUCLEOTIDYLEXOTRANSFERASE; ELAIDIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPOXYICOSATRIENOIC ACID; FIBRINOGEN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPASE A; POLYUNSATURATED FATTY ACID; PROTEIN BAX; TRANS FATTY ACID; VACCENIC ACID; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CELL VIABILITY; CHOLESTEROL DIET; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FIBRINOGEN BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HEART OUTPUT; HEART VENTRICLE FIBRILLATION; HUMAN; LINSEED; MICROTHROMBUS; NECROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; SODIUM CALCIUM EXCHANGE; WALNUT;

BIOLOGICAL MARKERS; FATTY ACIDS, UNSATURATED; HUMANS; REPERFUSION INJURY; TRANS FATTY ACIDS;

EID: 84889049735     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161281939131127111018     Document Type: Article

References (69)

1. Pierucci P, Misciagna G, Ventura MT, et al. Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy. Nutr Metab Cardiovasc Dis 2012; 22(9): 727-33.
2. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a metaanalysis of randomized controlled trials. Circulation 2005; 112(13): 1945-52.
3. Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009; 139(4): 804S-19S.
4. Dupasquier CM, Weber AM, Ander BO, et al. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 2006; 291(6): H2987-96.
5. Dupasquier CM, Dibrov E, Kneesh AL et al. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 2007; 293(4): H2394-402.
6. Cunnane SC, Chen ZY, Yang J, Liede AC, Hamadeh M, Crawford MA. Alpha-linolenic acid in humans: direct functional role or dietary precursor? Nutrition 1991; 7(6): 437-9.
7. Yamazaki K, Fujikawa M, Hamazaki T, Yano S, Shono T. Comparison of the conversion rates of alpha-linolenic acid (18: 3(n-3) and stearidonic acid (18: 4(n-3) to longer polyunsaturated fatty acids in rats. Biochim Biophys Acta 1992; 1123(1): 18-26.
8. Marchand V. Trans fats: What physicians should know. Paediatr Child Health 2010; 15(6): 373-8.
9. Ramsden C. E, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010; 104(11): 1586-600.
10. Mensink R. P. Dietary Fatty acids and cardiovascular health-an ongoing controversy. Ann Nutr Metab 2011; 58(1): 66-7.
11. Singh KK, Mridula D, Rehal J, Barnwal P. Flaxseed: a potential source of food, feed and fiber. Crit Rev Food Sci Nutr 2011; 51(3): 210-22.
12. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2(8081): 117-9.
13. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312(19): 1205-9.
14. Coombes R. Trans fats: chasing a global ban. BMJ 2011; 343: d5567.
15. Mozaffarian D, Aro A, Willett WC, Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009; 63 Suppl 2: S5-21.
16. Lemaitre RN, King IB, Raghunathan TE, et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002; 105(6): 697-701.
17. Flock MR, Kris-Etherton PM. Dietary Guidelines for Americans 2010: implications for cardiovascular disease. Curr Atheroscler Rep 2011; 13(6): 499-507.
18. Bassett CM, Edel AL, Patenaude AF et al. Dietary vaccenic acid has antiatherogenic effects in LDLr-/-mice. J Nutr 2010; 140(1): 18-24.
19. Gebauer SK, Chardigny JM, Jakobsen MU et al. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr 2011; 2(4): 332-54.
20. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123(4): e18-e209.
21. Wagner M, Siddiqui MA. Signaling networks regulating cardiac myocyte survival and death. Curr Opin Investig Drugs 2009; 10(9): 928-37.
22. Furlan AJ. Challenges in acute ischemic stroke clinical trials. Curr Cardiol Rep 2012; 14(6): 761-6.
23. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59(4): 418-58.
24. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54(23): 2129-38.
25. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010; 411(7-8): 584-91.
26. Lands WE. Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann N Y Acad Sci 2005; 1055: 179-92.
27. Hibbeln JR, Nieminen LR, Blasbalg TL, RIggs JA, Lands WE. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006; 83(6 Suppl): 1483S-1493S.
28. Okuyama H, Ichikawa Y, Sun Y, Hamazaki T, Lands WE. Omega3 fatty acids effectively prevent coronary heart disease and other lateonset diseases-the excessive linoleic acid syndrome. World Rev Nutr Diet 2007; 96: 83-103.
29. Clifton PM, Keogh JB, Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 2004; 134(4): 874-9.
30. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010; 21(9): 781-92.
31. Di Lisa F, Canton M, Carpi A, et al. Mitochondrial injury and protection in ischemic pre-and postconditioning. Antioxid Redox Signal 2011; 14(5): 881-91.
32. Bassett CM, McCullough RS, Edel AL et al. Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 2009; 58(12): 1802-8.
33. Bassett CMC, Edel AL, Patenaude AF, et al. Dietary vaccenic acid has anti-atherogenic effects in LDL r-/-mice. J Nutr 2010; 140: 18-24.
34. Abbey M, Nestel PJ. Plasma cholesteryl ester transfer protein activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet. Atherosclerosis 1994; 106(1): 99-107.
35. Leroy C, Tricot S, Lcour B, Grynberg A. Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes. Biochim Biophys Acta 2008; 1781(11-12): 685-93.
36. Fiaccavento R, Carontenuto F, Minieri M, et al. Alpha-linolenic acid-enriched diet prevents myocardial damage and expands lon gevity in cardiomyopathic hamsters. Am J Pathol 2006; 169(6): 1913-24.
37. Fang KM, Lee AS, Su MJ, Lin CL, Chien CL, Wu ML. Free fatty acids act as endogenous ionophores, resulting in Na+ and Ca2+ influx and myocyte apoptosis. Cardiovasc Res 2008; 78(3): 533-45.
38. Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1997; 94(8): 4182-7.
39. Ander BP, Hurtado C, Raposo CS, et al. Differential sensitivities of the NCX1. 1 and NCX1. 3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid. Cardiovasc Res 2007; 73(2): 395-403.
40. Falck JR, Wallukat G, Puli N, et al. 17(R), 18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues. J Med Chem 2011; 54(12): 4109-18.
41. Charnock J. S. Omega-3 polyunsaturated fatty acids and ventricular fibrillation: the possible involvement of eicosanoids. Prostaglandins Leukot Essent Fatty Acids 1999; 61(4): 243-7.
42. Saito Y, Watanabe K, Fujioka D, et al. Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemiareperfusion injury partly through inhibition of TNF-alpha-mediated pathway. Am J Physiol Heart Circ Physiol 2012; 302(10): H2018-30.
43. Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-gamma-independent manner. Basic Res Cardiol 2011; 106(3): 431-46.
44. Chen J, Capdevila JH, Zeldin DC, Rosenberg RL. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol Pharmacol 1999; 55(2): 288-95.
45. Xu X, Zhang XA, Wang DW. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev 2011; 63(8): 597-609.
46. Batchu SN, Lee SB, Qadhi RS, et al. Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. Br J Pharmacol 2011; 162(4): 897-907.
47. Bao Y, Wang X, Li, et al. 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrialdependent pathways. J Cardiovasc Pharmacol 2011; 57(3): 294-301.
48. Niu SL, Mitchell DC, Litman BJ. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005; 44(11): 4458-65.
49. de Vries JE, Vork MM, Roemen TH, et al. Saturated but not monounsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997; 38(7): 1384-94.
50. Tardy AL, Morio B, Chardigny JM, Malpuech-Brugere C. Ruminant and industrial sources of trans-fat and cardiovascular and diabetic diseases. Nutr Res Rev 2011; 1-7.
51. Micha R, Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009; 5(6): 335-44.
52. Park Y, Lim J, Kwon Y, Lee J. Correlation of erythrocyte fatty acid composition and dietary intakes with markers of atherosclerosis in patients with myocardial infarction. Nutr Res 2009; 29(6): 391-6.
53. Tissier C, Vandroux D, Devillard L, et al. Substrate dependence of the postischemic cardiomyocyte recovery: dissociation between functional, metabolic and injury markers. Mol Cell Biochem 2005; 273(1-2): 43-55.
54. Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators. Shock 2006; 26(3): 262-70.
55. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274(17): 1363-7.
56. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011; 58(20): 2047-67.
57. Khalfoun B, Sibue D, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit the CD28-lymphocyte activation pathway in vitro. Transplant Proc 1998; 30(8): 3978-9.
58. Khalfoun B, Gruel Y, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte proliferation induced by allogenic cells. Transplant Proc 1997; 29(5): 2397.
59. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 1997; 400B: 589-97.
60. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135(3): 562-6.
61. Viviani Anselmi C, Ferreri C, Novelli V, et al. Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. J Interv Card Electrophysiol 2010; 27(2): 95-9.
62. Lemaitre RN, King IB, Sotoodehnia K, et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010; 59(7): 1029-34.
63. Sun Q, Ma J, Campos H, Hu FB. Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr 2007; 86(4): 929-37.
64. Park S, Park Y. Effects of dietary fish oil and trans fat on rat aorta histopathology and cardiovascular risk markers. Nutr Res Pract 2009; 3(2): 102-7.
65. Tartibian B, Maleki BH, Abbasi A. Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men. Clin J Sport Med 2011; 21(2): 131-7.
66. Phillips T, Childs AC, Dreon DM, Phinney S, Leeuwenburh C. A dietary supplement attenuates IL-6 and CRP after eccentric exercise in untrained males. Med Sci Sports Exerc 2003; 35(12): 2032-7.
67. Moertl D, Hammer A, Steiner S, Hutuleac R, Vonbank K, Berger R. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study. Am Heart J 2011; 161(5): 915 e1-9.
68. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21(6): 495-505.
69. de Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 2009; 158(2): 413-28.